David W. Meline, Chief Financial Officer at Moderna, Inc. (MRNA), sold 1,238 shares at $158.89 ($197K) on 2022-02-10, disclosed to the SEC on 2022-02-11.
Open-market sale of $197k MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.89 | 619 | $98K | 50.0% |
| 2 | $158.89 | 619 | $98K | 50.0% |
| Total | $158.89 avg | 1,238 | $197K | 100% |
| Filing → |
| MRNA | SELL | 2022-05-11 | $21K | — | Filing → |
| AMGN | SELL | 2019-11-25 | $4.1M | — | Filing → |
| MMM | SELL | 2013-10-30 | $355K | — | Filing → |